---
layout: minimal-medicine
title: Chlorproguanil
---

# Chlorproguanil
### Generic Name
Chlorproguanil

### Usage
Chlorproguanil is an antimalarial drug.  Historically, it was primarily used in combination with dapsone, another medication. This combination was effective against malaria, but its use has been discontinued due to a significant risk of post-treatment hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency.  Therefore, chlorproguanil is no longer widely recommended for malaria treatment on its own or in combination with dapsone in standard medical practice.


### Dosage
Due to the discontinuation of chlorproguanil/dapsone combination therapy, specific dosage information is not readily available for current clinical use.  Any past dosage recommendations should not be followed without explicit guidance from a healthcare professional.


### Side Effects
Because chlorproguanil's use is largely obsolete due to safety concerns, detailed side effect information based on current clinical usage is limited.  However, past reports associated with its use in combination with dapsone indicated the potential for:

*   Hemolytic anemia (particularly in individuals with G6PD deficiency) â€“ a serious side effect involving the breakdown of red blood cells.
*   Gastrointestinal issues such as nausea, vomiting, and diarrhea.
*   Skin rashes.
*   Other potential, less common side effects.

**It is crucial to seek immediate medical attention if any adverse effects occur.**


### How it Works
Chlorproguanil is a proguanil derivative.  Proguanil itself is metabolized in the body to its active form, cycloguanil.  Cycloguanil inhibits dihydrofolate reductase (DHFR), an enzyme crucial for the synthesis of folic acid in malaria parasites. By inhibiting DHFR, cycloguanil interferes with the parasite's ability to produce DNA and RNA, ultimately leading to its death.


### Precautions
Given the discontinuation of chlorproguanil/dapsone for malaria treatment,  stringent precautions are essential. This medication should **not** be used without explicit consultation and guidance from a qualified healthcare professional. It is particularly crucial to be aware of:

*   **G6PD Deficiency:**  Individuals with G6PD deficiency are at extremely high risk of developing hemolytic anemia.  Chlorproguanil should absolutely be avoided in this population.
*   **Drug Interactions:**  The potential for interactions with other medications is unknown in the context of current limited use. Always inform your doctor of all medications you are taking.
*   **Pregnancy and Breastfeeding:**  The safety of chlorproguanil during pregnancy and breastfeeding is not established due to the lack of current usage.
*   **Children and Older Adults:**  Due to a lack of current clinical use, specific precautions related to these population groups are not established.


### FAQs

*   **Q: Is chlorproguanil still used to treat malaria?**
    *   A: No. The combination of chlorproguanil and dapsone was used, but its use has been discontinued due to the risk of hemolytic anemia.  There are currently safer and more effective antimalarial drugs.

*   **Q: What should I do if I experience side effects?**
    *   A: Immediately contact your healthcare provider.


*   **Q: Where can I get chlorproguanil?**
    *   A:  Because of its obsolete status in standard treatment, chlorproguanil is not commonly available through standard prescription channels.


**Disclaimer:** This information is for general knowledge and does not constitute medical advice. Always consult a healthcare professional for any health concerns or before making any decisions related to your health or treatment.  The information provided here reflects the limited current usage of Chlorproguanil.  Past usage patterns should not be considered current medical practice.
